Cotton Eyes Orphan Drug Program Tweaks; Highlights Price Hikes, Import Limits

Sen. Tom Cotton (R-AR) announced in a Feb. 16 floor speech that he will craft a legislative solution to price hikes associated with the orphan drug program, following news of an expected increase in the cost of a newly approved drug to treat Duchenne muscular dystrophy. Cotton joins Senate Judiciary Chairman Chuck Grassley (R-IA), Sen. Bernie Sanders (I-VT) and House oversight ranking Democrat Elijah Cummings (MD) in expressing concerns this month over FDA's orphan drug program. Cotton's floor speech also...